Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s):  CPHRF

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology... see more

TSX:CPH - Post Discussion

Cipher Pharmaceuticals Inc > Absorica Generic
View:
Post by pabaloo on Dec 31, 2020 12:20pm

Absorica Generic

So Activis/Teva have not submitted to launch a generic of Absorica as of yet? They could be selling as of December 27 but have not even looked for FDA approval as far as I can see. This leaves 9 more months of sales to Sun and Cipher. It will hopefully rule out other pharmas from entering this space as it may be too small a margin to profit trying to compete if Sun reduced prices.
looks like another few quarters of 4 million in revenue and .10 in profit.
Comment by pabaloo on Dec 31, 2020 12:26pm
Comment by pabaloo on Dec 31, 2020 12:29pm
          e-paper           HOME LATEST TRENDING MY READS         IterableTM O+cial Site Find Out Why Marketers Are Switching To Iterable's Growth Marketing Platform  iterable.com OPEN  Home >Markets >Mark To Market >Threat from competition aside, Sun Pharma sees steady growth prospects we h ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities